Ipsen Biopharmaceuticals implements enhanced patient support program

NewsGuard 100/100 Score

Program Provides Coverage, Access, Reimbursement, & Education Support Regarding Ipsen Medicines to Patients and their Healthcare Providers

Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY) today announced the implementation of IPSEN CARESTM (Coverage, Access, Reimbursement, & Education Support). Ensuring patients, providers and caregivers have the resources needed to help access the Ipsen medications that are critical to managing their conditions, IPSEN CARES is staffed Monday to Friday by experts who can assist with a broad range of medical, educational, logistical and coverage information regarding Ipsen medicines, including Increlex® (mecasermin), Somatuline® Depot® (lanreotide), and Dysport® (abobotulinumtoxinA).

“At Ipsen, improving the lives of patients is what drives us each and every day,” said Cynthia Schwalm, President and CEO, Ipsen N.A. “We are committed to providing information and support to our patients to help them access, receive and properly use our medications.

Involving the entire treatment team that surrounds patients on a daily basis, IPSEN CARES can provide benefits verification (research of a patient’s medical or pharmacy benefit insurance coverage); prior authorization information; a patient assistance program (free medications for uninsured patients); co-pay assistance programs; billing and coding support; coordination with specialty pharmacies; injection training and adherence calls.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Aster DM Healthcare reveals top foods to combat PCOS symptoms